GeneNews (TSX:GEN) is dedicated to providing innovative solutions for early cancer detection. Our Mission is to Reduce Late Stage Cancers by 50% Within the Next 10 Years
Our mission is to identify, assess and make commercially available a comprehensive menu of diagnostics that provide physicians and patients with personalized clinical intelligence and actionable information to improve health outcomes through the early diagnosis of disease. We also work with large healthcare systems to develop and implement processes that lead to higher screening rates and improved metrics around performance and care.
GeneNews' diagnostic areas are:
- Colon Cancer
- Lung Cancer
- Prostate Cancer
- Breast Cancer
Its innovative diagnostics and measurable programs address an unmet clinical need: Reaching the underscreened